Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Stoke Therapeutics (STOK) Interest & Investment Income: 2022-2024

Historic Interest & Investment Income for Stoke Therapeutics (STOK) over the last 3 years, with Dec 2024 value amounting to $12.6 million.

  • Stoke Therapeutics' Interest & Investment Income fell 2.31% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.1 million, marking a year-over-year increase of 7.00%. This contributed to the annual value of $12.6 million for FY2024, which is 27.55% up from last year.
  • According to the latest figures from FY2024, Stoke Therapeutics' Interest & Investment Income is $12.6 million, which was up 27.55% from $9.9 million recorded in FY2023.
  • In the past 5 years, Stoke Therapeutics' Interest & Investment Income registered a high of $12.6 million during FY2024, and its lowest value of $3.1 million during FY2022.
  • Moreover, its 3-year median value for Interest & Investment Income was $9.9 million (2023), whereas its average is $8.6 million.
  • Data for Stoke Therapeutics' Interest & Investment Income shows a peak YoY skyrocketed of 217.36% (in 2023) over the last 5 years.
  • Stoke Therapeutics' Interest & Investment Income (Yearly) stood at $3.1 million in 2022, then soared by 217.36% to $9.9 million in 2023, then grew by 27.55% to $12.6 million in 2024.